778 results on '"Caramella, C."'
Search Results
2. Classification CAD-RADS 2.0 : regards croisés radiologue-cardiologue sur son utilisation pratique
3. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease
4. Three artificial intelligence data challenges based on CT and MRI
5. Artificial intelligence solution to classify pulmonary nodules on CT
6. Place de l’immunothérapie dans le cancer bronchique non à petites cellules localement avancé
7. Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI
8. Nouveaux outils en cancérologie thoracique
9. P1.18-03 Patients with Smoking-Associated Atherosclerotic Cardiovascular Diseases: Does Prevalung Refines Eligibility for Screening?
10. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel
11. Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
12. Osimertinib benefit inEGFR-mutant NSCLC patients withT790M-mutation detected by circulating tumour DNA
13. Standardised lesion segmentation for imaging biomarker quantitation:a consensus recommendation from ESR and EORTC
14. 1090P HER2 copy number variation in non-small cell lung cancer (NSCLC)
15. 941P PET-derived parameters for response assessment in neoadjuvant atezolizumab: A secondary analysis of PRINCEPS phase II trial
16. Place de l’IRM corps entier dans l’évaluation des tumeurs de l’enfant
17. Whole body MRI in paediatric oncology
18. Ionic polymeric micelles based on chitosan and fatty acids and intended for wound healing. Comparison of linoleic and oleic acid
19. Métastases hépatiques, pulmonaires et péritonéales des cancers colorectaux
20. Liver, lung and peritoneal metastases in colorectal cancers: Is the patient still curable? What should the radiologist know
21. EP.04C.04 Extended Inclusion Criteria for Lung Cancer Screening to Tabacco Related Diseases: Comparison of Preliminary Results in Two Prospective Cohorts
22. Alpha tocopherol loaded chitosan oleate nanoemulsions for wound healing. Evaluation on cell lines and ex vivo human biopsies, and stabilization in spray dried Trojan microparticles
23. Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery
24. Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?
25. Prognostic significance of visible cardiophrenic angle lymph nodes in the presence of peritoneal metastases from colorectal cancers
26. Carvacrol/clay hybrids loaded into in situ gelling films
27. Therapeutic Strategies for Advanced Pancreatic Neuroendocrine Tumors with Segmental Portal Hypertension
28. Screening in asymptomatic SDHx mutation carriers: added value of 18F-FDG PET/CT at initial diagnosis and 1-year follow-up
29. PO-1246 Lung SBRT after pneumonectomy
30. Clay minerals for tissue regeneration, repair, and engineering
31. List of contributors
32. Preparation and characterization of polysaccharide-based nanoparticles with anticoagulant activity
33. Assessement of anti-inflammatory properties of microspheres prepared with chitosan and 5-amino salicylic acid over inflamed Caco-2 cells
34. Chitosan–silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA)
35. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis
36. P62.01 PREVALUNG: Evaluation of Lung Cancer Prevalence in Patients With Smocking-associated Atherosclerotic Cardiovascular Diseases
37. 1355P Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC
38. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
39. iRECIST pour les nuls
40. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers (Jan , 10.1007/s00330-020-07598-8, 2021)
41. Caractérisation des tumeurs neuroendocrines digestives ou thoraciques
42. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers
43. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]
44. Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers
45. Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers
46. Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront [FP07.06]
47. 1734P Early impact of a personalized lung cancer interception program for heavy smokers
48. Therapeutic Management of Advanced Adrenocortical Carcinoma: What Do We Know in 2011?
49. Endocrine pancreatic tumours: which are the most useful MRI sequences?
50. Thermal characterization of diltiazem and λ-carrageenan binary systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.